TRP_1170x120_3-8-19

Frank Segrave

Silvergate Pharmaceuticals releases Xatmep Oral Solution

Silvergate Pharmaceuticals releases Xatmep Oral Solution

DENVER — Silvergate Pharmaceuticals Inc. has launched Xatmep Oral Solution (methotrexate 2.5 mg/ml), a medication used for leukemia and arthritis in children. Silvergate said Xatmep is the first and only Food and Drug Administration-approved methotrexate oral solution and will be available via an extensive network of pharmacies. Xatmep is indicated for the treatment of acute

Bartell Drugs announces new board members

Bartell Drugs announces new board members

SEATTLE  — Bartell Drugs has elected three new members to its board of directors. The Puget Sound-area drug chain said Tuesday that veteran business executives Kathy Gersch, Mark Schwartz and Kristi Marchbanks have joined the Bartell Drugs board, bringing range of strategic, entrepreneurial and cross-industry experience to the company. “We are delighted to add these

Bartell adds Segrave to its board

SEATTLE — Former Walmart vice president of pharmacy Frank Segrave has joined the board of directors at Bartell Drugs. On the drug chain’s board, Segrave replaces Brian Unmacht, who was appointed as president and chief executive officer of Bartell Drugs in April. Unmacht joined Bartell’s management as president in January and has served on the

Pharmacy veteran Segrave joins Bartell Drugs’ board

Pharmacy veteran Segrave joins Bartell Drugs’ board

SEATTLE — Frank Segrave, president and chief executive officer of Silvergate Pharmaceuticals and former vice president of pharmacy at Walmart, has joined the board of directors of Bartell Drugs. On the Seattle-area drug chain’s board, Segrave replaces Brian Unmacht, who was appointed as president and CEO of Bartell Drugs in April earlier this year. Unmacht